{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:13:24Z","timestamp":1793308404397,"version":"4.5.0"},"reference-count":63,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["PM&amp;R"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:label\/><jats:p>Prior to FDA approval of intradetrusor botulinum toxin (BoTA) injections for the treatment of neurogenic bladder, patients' treatment options were limited to use of pharmacotherapies such as antimuscarinics, alpha blockers, and more recently beta agonists (some off\u2010label) or invasive interventions including bladder augmentation and urinary diversion procedures. Herein, we provide a comprehensive literature review detailing the salient clinical literature that led to FDA approval of intradetrusor BoTA for neurogenic bladder. Patients with neurogenic detrusor overactivity and detrusor sphincter dyssynergia have been shown in randomized studies to benefit significantly from intradetrusor BoTA injection with regard to the following parameters: improved voided volume, improved bladder pressure and urodynamic parameters, reduced incidence of urinary tract infection, and improved quality of life. Intradetrusor BoTA injection has revolutionized the treatment landscape for patients with neurogenic bladder by providing them with a safe, efficacious, and cost\u2010effective means to reduce bladder dysfunction, preserve renal function, and reduce the need for invasive, surgical intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Level of Evidence<\/jats:title><jats:p>I<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.pmrj.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T02:35:40Z","timestamp":1534818940000},"page":"192-200","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Review of Botulinum Toxin A for the Treatment of Neurogenic Bladder"],"prefix":"10.1002","volume":"11","author":[{"given":"Lauren Folgosa","family":"Cooley","sequence":"first","affiliation":[{"name":"Department of Urology Northwestern University Feinberg School of Medicine  Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-1675","authenticated-orcid":false,"given":"Stephanie","family":"Kielb","sequence":"additional","affiliation":[{"name":"Department of Urology Northwestern University Feinberg School of Medicine  303 E Chicago Ave, Tarry 16\u2010703 Chicago Illinois 60611"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2401"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04520413"},{"key":"e_1_2_5_4_1","first-page":"5","article-title":"Urinary incontinence in neurological disease: Management of lower urinary tract dysfunction in neurological disease","volume":"148","author":"Harrison S","year":"2012","journal-title":"Clinical Guideline"},{"key":"e_1_2_5_5_1","first-page":"657","article-title":"Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013","volume":"35","author":"Drake MJ","year":"2016","journal-title":"NeurourolUrodyn"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2017.04.012"},{"issue":"3","key":"e_1_2_5_7_1","first-page":"2","article-title":"Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder","volume":"22","author":"Habb F","year":"2014","journal-title":"NeurourolUrodyn"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.11.061"},{"key":"e_1_2_5_9_1","first-page":"127","article-title":"Detrusor sphincter dyssynergia: A review of physiology, diagnosis and treatment strategies","volume":"5","author":"Stofell JT","year":"2016","journal-title":"Transl Androl Urol"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08438.x"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sc.2013.19","article-title":"Neurogenic detrusor overactivity in adults: A review on efficacy, tolerability and safety of oral antimuscarinics","volume":"51","author":"Madersbacher H","year":"2013","journal-title":"Spinal Cord"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1995.tb07264.x"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000282207"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.1996.51"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3100995"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.05.056"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67524-4"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2003.00710.x"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S29644"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1308\/003588406X95101"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67800-7"},{"key":"e_1_2_5_22_1","first-page":"117","article-title":"Neuromodulation in neurogenic bladder","volume":"5","author":"Sanford MT","year":"2016","journal-title":"Transl Androl Urol"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.11.073"},{"key":"e_1_2_5_24_1","first-page":"1909","volume-title":"Campbell\u2010Walsh Urology","author":"Wein AJ","year":"2011"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-015-2771-0"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.09.024"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2010.176"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2017.04.013"},{"key":"e_1_2_5_29_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11884-015-0334-3","article-title":"Evaluation and management of failed bladder reconstructions","volume":"1","author":"Jordan BJ","year":"2015","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000140911.43898.15"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00443-4"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.08.038"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08401.x"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euus.2004.09.004"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.12.006"},{"key":"e_1_2_5_36_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins8030059","article-title":"Botulinum toxin A in the treatment of overactive bladder","volume":"8","author":"Hsieh P","year":"2016","journal-title":"Toxins"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1439"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.1.189"},{"key":"e_1_2_5_39_1","unstructured":"USFoodandDrug Administration. BOTOX (onabotulinumtoxinA)2011:1\u201344.www.accessdata.fda.gov"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42717-0"},{"key":"e_1_2_5_41_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/toxins8040088","article-title":"Use of botulinum toxin A in the treatment of lower urinary tract disorders: A review of the literature","volume":"8","author":"DC, Cohn JA, Dmochowski RR Moore","year":"2016","journal-title":"Toxins"},{"key":"e_1_2_5_42_1","first-page":"6650","article-title":"Intradetrusor onabotulinumtoxinA injection: How I do it","volume":"20","author":"Shenot PJ","year":"2013","journal-title":"Can J Urol"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.002"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.01.125"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.05.136"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.10.047"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-014-2499-2"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2015.143"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.08.028"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.11.010"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.045765"},{"key":"e_1_2_5_52_1","first-page":"793","article-title":"Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion","volume":"27","author":"Kuo HC","year":"2008","journal-title":"NeurourolUrodyn"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2009.11.006"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0255"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2011.11.020"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3101593"},{"key":"e_1_2_5_57_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0970-1591.109975","article-title":"The use of botulinum toxin for the treatment of overactive bladder syndrome","volume":"29","author":"Orasanu B","year":"2013","journal-title":"Ind J Urol"},{"key":"e_1_2_5_58_1","first-page":"2","article-title":"Agency for Clinical Innovation","author":"Middleton J","year":"2014","journal-title":"Chatswood"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000206213.48334.09"},{"key":"e_1_2_5_60_1","unstructured":"Centers for Medicare and Medicaid Services.2016Medicare physician final fee schedule reimbursement and RVU changes.https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched\/."},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1995.tb05528.x"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2014.79"},{"key":"e_1_2_5_63_1","unstructured":"Centers for Medicare and Medicaid Services. April2018Drug Pricing Files.https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Part-B-Drugs\/McrPartBDrugAvgSalesPrice\/2018ASPFiles.html."},{"key":"e_1_2_5_64_1","unstructured":"Centers for Medicare and Medicaid Services. Physician Fee Schedule Search.https:\/\/www.cms.gov\/apps\/physician\u2010fee\u2010schedule\/overview.aspx."}],"container-title":["PM&amp;R"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.pmrj.2018.07.016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934148218308475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934148218308475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.pmrj.2018.07.016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T07:54:48Z","timestamp":1694678088000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.pmrj.2018.07.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1016\/j.pmrj.2018.07.016"],"URL":"https:\/\/doi.org\/10.1016\/j.pmrj.2018.07.016","archive":["Portico"],"relation":{},"ISSN":["1934-1482","1934-1563"],"issn-type":[{"value":"1934-1482","type":"print"},{"value":"1934-1563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"2018-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}